HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma

L Li, YL Zheng, C Jiang, S Fang, TT Zeng… - Cell Death & …, 2019 - nature.com
Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies and lacks
targeted therapies. Here, we reported a novel potential therapeutic target hematological and …
被引用次数：63 相关文章

HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma.

L Li, YL Zheng, C Jiang, S Fang, TT Zeng… - Cell Death and …, 2019 - europepmc.org
Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies and lacks
targeted therapies. Here, we reported a novel potential therapeutic target hematological and …

HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma

L Li, YL Zheng, C JIANG, S FANG, TT Zeng… - Cell Death and …, 2019 - hub.hku.hk
Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies and lacks
targeted therapies. Here, we reported a novel potential therapeutic target hematological and …
[PDF] researchgate.net

[PDF][PDF] HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma

L Li, YL Zheng, C Jiang, S Fang, TT Zeng, YH Zhu, Y Li… - 2019 - researchgate.net
Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies and lacks
targeted therapies. Here, we reported a novel potential therapeutic target hematological and …
[HTML] nih.gov

[HTML][HTML] HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma

L Li, YL Zheng, C Jiang, S Fang, TT Zeng… - Cell Death and …, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies and lacks
targeted therapies. Here, we reported a novel potential therapeutic target hematological and …

HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma

L Li, YL Zheng, C Jiang, S Fang… - Cell death and …, 2019 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies and lacks
targeted therapies. Here, we reported a novel potential therapeutic target hematological and …

HN1L-mediated transcriptional axis AP-2 gamma/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma

L Li, YL Zheng, C Jiang, S Fang, TT Zeng… - Cell Death and …, 2019 - hero.epa.gov
Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies and lacks
targeted therapies. Here, we reported a novel potential therapeutic target hematological and …

HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma.

L Li, YL Zheng, C Jiang, S Fang, TT Zeng… - Cell Death and …, 2019 - europepmc.org
Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies and lacks
targeted therapies. Here, we reported a novel potential therapeutic target hematological and …